GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami N ShahDesignation :- Company Secretary and Compliance Officer GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions , the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives)from Thursday, October 01, 2020 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter ended September 30, 2020. The date of meeting of the Board of Directors to consider and approve the Un-Audited Financial Result of the Company for the quarter and half year ended September 30, 2020 will be informed in due course. GUFIC BIOSCIENCES LTD. - 509079 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here GUFIC BIOSCIENCES LTD. - 509079 - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosures Requirements, 2015 Details Of The Voting Results Of The Business Transacted At The National Company Law Tribunal, Mumbai Bench (NCLT) Convened General Meeting Of The Equity Shareholders Of The Company.
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we enclose herewith the details regarding the voting results of the business transacted at the NCLT convened Meeting of the Equity Shareholders of the Company held on Tuesday, September 15, 2020 at 12.30 p.m. through Video Conferencing in the prescribed format. Further, the report submitted by the Scrutinizer, Mr. Gajanan D. Athavale, Practicing Company Secretary for postal ballot, remote e-voting (prior to the Meeting) and e-voting during the course of the Meeting, is also enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Shareholding Meeting On September 15, 2020 At 12.30 P.M
Pursuant to the order dated July 14 , 2020 passed by the Hon'ble National Company Law Tribunal, Special bench, Mumbai (NCLT),the Meeting of the Equity Shareholders of the Company was held on September 15, 2020 at 12.30 p.m through Video conferencing to approve Scheme of Amalgamation (Merger by Absorption) of Gufic Lifesciences Private Limited with the Company and their respective shareholders and creditors. You are requested to kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
The Board of Directors on recommendation of the Audit Committee of the Company, approved the appointment of M/s. Mittal Agarwal & Co., Chartered Accountants (Registration No. ICAI FRN: 131025W) as Statutory Auditors of the Company to fill the casual vacancy arising out of resignation of the existing statutory auditor. The said appointment shall be placed for shareholders'' approval at the ensuing Annual General Meeting. Pursuant to SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 a brief profile of M/s. Mittal Agarwal & Co., is enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Outcome Of Board Meeting Held On 14Th September, 2020.
The Board of Directors in their meeting held on 14th September, 2020 considered and approved the matters as stated in the enclosed letter. GUFIC BIOSCIENCES LTD. - 509079 - Results-Financial Results For June 30, 2020
The Board of Directors approved the Un-Audited Financial Results for the quarter ended June 30, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Enclosed herewith is the copy of the Un-Audited Financial Results for the Quarter ended June 30 , 2020, Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter ended June 30 , 2020 and Management Report giving highlights for the quarter ended June 30, 2020. GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of the Code of Conduct of the Company, the trading window for dealing in securities of the Company which is closed from Wednesday, 1st April, 2020 shall continue to remain closed and shall re-open on the expiry of 48 hours from the declaration of the financial results for the quarter ended 30th June, 2020. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2020
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/09/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, September 14, 2020, inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2020.